Literature DB >> 20156781

Breast Cancer OncoGuia.

Paula Manchon1, Josep M Borràs, Tàrsila Ferro, Josep Alfons Espinàs.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20156781     DOI: 10.1007/s12094-010-0477-9

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  177 in total

1.  Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy.

Authors:  P I Haigh; N M Hansen; A E Giuliano; G K Edwards; W Ye; E C Glass
Journal:  J Nucl Med       Date:  2000-10       Impact factor: 10.057

2.  [2006 technology monitoring report: clinical practice guideline: use of FDG-PET in kidney, prostate, testis and bladder cancers].

Authors:  Patrick Bourguet; François Planchamp; Françoise Montravers; Sébastien Vincendeau
Journal:  Prog Urol       Date:  2007-04       Impact factor: 0.915

3.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

Authors:  M Overgaard; M B Jensen; J Overgaard; P S Hansen; C Rose; M Andersson; C Kamby; M Kjaer; C C Gadeberg; B B Rasmussen; M Blichert-Toft; H T Mouridsen
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

4.  Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.

Authors:  K S Nason; B O Anderson; D R Byrd; L K Dunnwald; J F Eary; D A Mankoff; R Livingston; R A Schmidt; K D Jewell; R S Yeung; R E Moe
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

5.  Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study.

Authors:  J Bonneterre; B Thürlimann; J F Robertson; M Krzakowski; L Mauriac; P Koralewski; I Vergote; A Webster; M Steinberg; M von Euler
Journal:  J Clin Oncol       Date:  2000-11-15       Impact factor: 44.544

6.  American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines.

Authors:  T J Smith; N E Davidson; D V Schapira; E Grunfeld; H B Muss; V G Vogel; M R Somerfield
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

7.  Lymphatic Mapping and Sentinel Lymph Node Biopsy.

Authors:  Siddharth S. Bass; Gary H. Lyman; Christa R. McCann; Ni Ni Ku; Claudia Berman; Kara Durand; Monica Bolano; Sarah Cox; Christopher Salud; Douglas S. Reintgen; Charles E. Cox
Journal:  Breast J       Date:  1999-09       Impact factor: 2.431

8.  Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials.

Authors: 
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

9.  Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.

Authors:  C K Osborne; J Pippen; S E Jones; L M Parker; M Ellis; S Come; S Z Gertler; J T May; G Burton; I Dimery; A Webster; C Morris; R Elledge; A Buzdar
Journal:  J Clin Oncol       Date:  2002-08-15       Impact factor: 44.544

10.  Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography.

Authors:  Tunetake Hata; Hiromasa Takahashi; Kenichi Watanabe; Masato Takahashi; Kazunori Taguchi; Tomoo Itoh; Satoru Todo
Journal:  J Am Coll Surg       Date:  2004-02       Impact factor: 6.113

View more
  2 in total

Review 1.  Therapeutic Physical Exercise Post-Treatment in Breast Cancer: A Systematic Review of Clinical Practice Guidelines.

Authors:  Alicia Del-Rosal-Jurado; Rita Romero-Galisteo; Manuel Trinidad-Fernández; Manuel González-Sánchez; Antonio Cuesta-Vargas; Maria Ruiz-Muñoz
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

2.  Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, Spain.

Authors:  R Font; J A Espinas; M Gil-Gil; A Barnadas; B Ojeda; I Tusquets; M A Segui; M Margelí; A Arcusa; A Prat; M Garcia; J M Borras
Journal:  Br J Cancer       Date:  2012-09-06       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.